Gnosis by Lesaffre
137 rue Gabriel Péri
Marcq-en-Baroeul
59700
France
ACTIVE CATEGORIES
At Gnosis by Lesaffre, we harness the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and wellbeing.
We draw on our focused research and development capabilities, rigorous quality and regulatory standards, and extensive clinical validation procedures so that we can effectively collaborate with nutraceutical and pharmaceutical brands to develop game-changing products that help their customers thrive. We relentlessly explore the potential of microbial biotransformation–an untapped, transformative resource–to develop natural, sustainable, and efficacious solutions.
Products / Markets
Quatrefolic®: metabolic active form of folate, available for its biological action, ubiquitous in all body cells for benefit health and wellbeing.
ibSium®: (Saccharomyces cerevisiae CNCM I-3856) is an exclusive beneficial live yeast designed to support a complete intestinal comfort.
VitaMK7®: the naturally fermented vitamin K2 in the form of menaquinone-7 (MK7), produced by Gnosis in its own European manufacturing site through a patent granted biofermentation process.
Quatreflora™: a patented and proprietary strain Saccharomyces cerevisiae CNCM I-3856 indicated for vaginal infections caused by fungi and bacteria.
Mythocondro®: the first Non-Animal Chondroitin Sulfate produced by a patented, green, non-animal fermentation-based manufacturing process with a level of use lower than those of animal CS
Adonat®: the S-Adenosylmethionine, the most important methylating agent of human body.
Noochy Crisp™: First extruded nutritional yeast with an excellent nutritional profile full of nutrients, making it a must-have for health meals and snacks. Consumers will discover a new way to consume nutritional yeast thanks to the crunchiness of Noochy Crisp™
MenaQ7®: the only clinically proven vitamin K2 for bone and heart health. With over 20 clinical studies that prove safe and effective health benefits, MenaQ7’s ironclad science portfolio gives you the confidence that your products will deliver promised health benefits and the ability to offer claims that will gain attention on crowded shelves.

NUTRITION & HEALTH NEWS
26 Apr 2022 --- As Vitafoods is around the corner, companies are gearing up for launches ranging from immunity to probiotics and sports nutrition, while showcasing developments in cannabidiol (CBD)... Read More
FOOD INGREDIENTS NEWS
10 Nov 2021 --- Lesaffre is launching a baking center in Dubai as part of a network expansion strategy to support customers from the United Arab Emirates (UAE) and the greater Gulf Cooperation... Read More
BUSINESS NEWS
10 Apr 2019 --- Lesaffre has officially opened its first Baking Center that is 100 percent dedicated to industrial customers, where tests can be run at full scale. Located in the south of Vienna,... Read More
FOOD INGREDIENTS NEWS
23 Jan 2018 --- Mythocondro has reached the Union List of Novel Foods in accordance with the Novel Food Regulation (EU) 2015/2283 and the subsequent Commission Implementing Regulation (EU)... Read More

28 Jun 2021 --- Following Lesaffre’s recent microbiota online seminar, Sophie Legrain-Raspaud, research and application director for Gnosis by Lesaffre, shares how the microbiota field reaches beyond human health research to animal, plant and fermentation studies. Her colleague Hassina Ait-Abderrahim, director of in vitro and bacteria platforms, also details Lesaffre’s latest emerging technologies and upcoming research.
12 Jan 2021 --- Gnosis by Lesaffre, a business unit of the Lesaffre Group, harnesses the power of microorganisms and biotransformation processes like fermentation. This is used to cultivate nutritional actives and probiotics, as well as nutritional and functional yeasts that benefit human health and well-being.


THE WORLD OF FOOD INGREDIENTS
10 Dec 2015 --- Lesaffre is strengthening its presence in the nutritional ingredients fermentation and human health sector. It recently acquired Gnosis, an Italian company specialized in the development, production and sale of fermentation ingredients for the pharma, nutraceutical, cosmetic and veterinary industries.